Cleveland Clinic researchers contradict notion that most adult myeloid neoplasms occur sporadically
Takeaways from Cleveland Clinic’s hematology/medical oncology experts
Patient outcomes better with nanoparticle paclitaxel
Efficacy similar to IMRT with less toxicity
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A potential cancer therapeutic target
Researchers consider alternatives for high-risk patients
Learn about featured Cancer clinical trials currently enrolling, or search our Cancer clinical trials database for all open and accruing studies
MEK inhibitors can render them vulnerable to radiation
Study involved more than 3,000 patients at 10 institutions
Novel nomogram may help identify patients at higher risk
Advertisement
Advertisement